GB-109

N/A

Report date: 2024/09/19 16:51:12

Base Information

Drug NameGB-109
Drug Alias NameGB-109
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionHGF gene transference
TargetsHepatocyte growth factor
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesG&P Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesG&P Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A